InsidersTradesSigma
Follow the Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China stock price and the full management transaction log of the company, a listed equity based in Italy. Shares trade on the IT market, under the authority of Consob. Operating in the Health Care sector, Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China has logged 1 public disclosures. Market capitalisation: €796.7m. The latest transaction was reported on 18 November 2024 (Other). The full history is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,621 of 29,063 companies
61.7
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 November 2024
About Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China
Pharmanutra S.p.a. is a company focused on the health and pharmaceutical sector. It recently reported its first significant sales results in China.